Furthermore, urokinase plasminogen activator receptor (uPAR)-targeted delivery of antigomiR-21 and antagomir-10b in polylactic-co-glycolic acid (PLGA)-based nanoparticles substantially reduced breast tumor growth (Figure 4b) [101]. This evidence concerns the gene PLAUR and breast neoplasm.